Deerfield Private Design Fund IV, L.P.'s Net Worth

$0

Estimate Recalculated Apr 28, 2026 11:33PM EST

Who is Deerfield Private Design Fund IV, L.P.

Deerfield Private Design Fund IV, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DFP HEALTHCARE ACQUISITIONS CORP., Nkarta, Inc., Revolution Medicines, Inc., Singular Genomics Systems, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., ARVINAS INC., Schrodinger, Inc., AdaptHealth Corp., Larimar Therapeutics, Inc., PROTEON THERAPEUTICS INC, Cabaletta Bio, Inc., Annexon, Inc., Frequency Therapeutics, Inc., and ARS Pharmaceuticals, Inc..

SEC CIK

Deerfield Private Design Fund IV, L.P.'s CIK is 0001680307

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncology Institute, Inc.

Investor
Updated Nov 16, 2021
Nov 12
Mar 13
Showing 3 results

Nkarta, Inc.

Investor
Updated Jul 14, 2020
Jul 14
Showing 2 results

Revolution Medicines, Inc.

Investor
Updated Feb 18, 2020
Feb 18
Showing 2 results

Singular Genomics Systems, Inc.

Investor
Updated Jun 03, 2021
Jun 01
Showing 2 results

Edgewise Therapeutics, Inc.

Investor
Updated Mar 30, 2021
Mar 30
Showing 2 results

Nuvalent, Inc.

Investor
Updated Oct 24, 2024
Oct 22
Nov 03
Aug 02
557.40K
Showing 4 results

Mirum Pharmaceuticals, Inc.

Investor
Updated Jun 08, 2022
Jun 06
3.28MJul 09
Jul 02 - Jul 07
Jul 22
Showing 5 results

ARVINAS INC.

Investor
Updated Oct 01, 2018
Oct 01
Showing 2 results

Schrodinger, Inc.

Investor
Updated Feb 10, 2020
Feb 10
Showing 2 results

AdaptHealth Corp.

Investor
Updated Mar 12, 2024
Mar 08 - Mar 12
13.61M
Nov 08
8.57MApr 02
Feb 21
7.00M
Showing 6 results

Larimar Therapeutics, Inc.

Investor
Updated Feb 16, 2024
Feb 16
Sep 16
Jun 30
6.09M
Showing 4 results

PROTEON THERAPEUTICS INC

Investor
Updated Aug 04, 2017
1.22M
Showing 1 results

Cabaletta Bio, Inc.

Investor
Updated Oct 30, 2019
Oct 29
Showing 2 results

Annexon, Inc.

Investor
Updated Jul 28, 2020
Jul 28
Showing 2 results

Frequency Therapeutics, Inc.

Investor
Updated Oct 07, 2019
Oct 07
Showing 2 results

ARS Pharmaceuticals, Inc.

Investor
Updated Nov 10, 2022
11.08M
Showing 1 results